Rather than serving as a first-line treatment, it is typically considered an adjunctive therapy that may complement more established approaches, such as physical therapy, exercise modification, and other evidence-based interventions
While a provider should confirm a deficiency first, certain groups tend to benefit most from a weekly schedule during active treatment
This is usually a 29 to 31-gauge needle that is 1/2 inch or 5/16 inch long, which is ideal for injecting into the fatty tissue layer with minimal discomfort
This dual-pathway formulation allows researchers to study complementary repair mechanisms within a single, standardized reagent
if it is extremely low, good methylation can be assumed
Each therapy is backed by evidence-based protocols, ensuring safety and efficacy